PIPC supports new comparative effectiveness research proposal

The Partnership to Improve Patient Care (PIPC), a non-partisan, patient- focused, grassroots organization focused on securing patient-centered comparative effectiveness research (CER) voiced its strong support of the comparative effectiveness research provisions in Senate Finance Committee Chairman Max Baucus’s health reform proposal released today.

“Patients and health care providers across the country can benefit from the strong, patient-centered approach to comparative effectiveness research that is included in this proposal,” PIPC Chairman and epilepsy patient Tony Coelho said. “Sen. Baucus’s measure creates an independent Institute governed by patients, providers, government officials and other stakeholders, and further strengthens safeguards to protect patient access to the treatment options they need. This provides a sound framework for independent, sustained, and objective research that is focused on the needs of patients.”

“By creating an independent research Institute and including significant patient safeguards, the CER provisions will ensure that relevant, credible data is available to patients and their healthcare providers, and help ensure that information is used to inform treatment options, not limit them,” Mr. Coelho said.

Sen. Baucus’s measure includes expanded patient safeguards including a focus on clinical effectiveness research, not cost-effectiveness; and provisions to ensure that the Centers for Medicare and Medicaid Services will not misuse CER results in ways that overlook differences in patient needs or discriminate against the elderly or people with disabilities.

“The most important stakeholder in the medical community is the patient,” Mr. Coelho said. “Sen. Baucus’s proposal puts patients at the center of comparative effectiveness research, providing assurance that research will be focused on improving patient care and not cutting costs by restricting access to treatment options.”

PIPC also supports similar legislation (H.R. 2502) that has been introduced in the House by Rep. Kurt Schrader and 18 cosponsors, and an amendment, proposed by Delegate Christensen, that is currently pending before the Energy and Commerce Committee.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine